30.47

1.17% -0.28

Twist Bioscience Corp (TWST)

Overview News Price History Option Chain Discussions Forecast

Twist Bioscience Corp stock is currently priced at $30.47, with a 24-hour trading volume of 253.39K. It has seen a -1.17% decreased in the last 24 hours and a -11.22% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $30.98 pivot point. If it approaches the $30.05 support level, significant changes may occur.

Previous Close:

$30.75

Open:

$29.78

24h Volume:

253.39K

Market Cap:

$1.78B

Revenue:

$262.36M

Net Income/Loss:

$-205.80M

P/E Ratio:

-8.2351

EPS:

-3.7

Net Cash Flow:

$-128.84M

1W Performance:

+7.16%

1M Performance:

-11.22%

6M Performance:

+98.37%

1Y Performance:

+137.79%

1D Range:

$29.76

$30.76

52W Range:

$11.46

$43.21

Twist Bioscience Corp Stock (TWST) Company Profile

Name

Twist Bioscience Corp

Sector

Healthcare (1201)

Industry

Diagnostics & Research (66)

Phone

800-719-0671

Address

455 Mission Bay Boulevard South, Suite 545, San Francisco, CA

Employee

221

Twitter

@TwistBioscience

Next Earnings Date

2024-05-02

Latest SEC Filings

TWST's Discussions on Twitter

Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-17-24	Upgrade	Goldman	Neutral → Buy
Sep-27-23	Initiated	Berenberg	Buy
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral
Apr-12-21	Initiated	Piper Sandler	Overweight
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral

View All

Twist Bioscience Corp Stock (TWST) Latest News

Analyst Scoreboard: 5 Ratings For Twist Bioscience

Benzinga

Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip

Benzinga

Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed

Benzinga

Cathie Wood Trims Nvidia, Shopify Stakes To Pump Whopping $40M Into Pinterest Despite Q4 Revenue Miss

Benzinga

Cathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3M

Benzinga

4 Analysts Have This To Say About Twist Bioscience

Benzinga

Twist Bioscience Corp Stock (TWST) Financials Data

Twist Bioscience Corp (TWST) Revenue 2024

TWST reported a revenue (TTM) of $262.36 million for the quarter ending December 31, 2023, a +21.58% rise year-over-year.

Twist Bioscience Corp (TWST) Net Income 2024

TWST net income (TTM) was -$205.80 million for the quarter ending December 31, 2023, a +3.89% increase year-over-year.

Twist Bioscience Corp (TWST) Cash Flow 2024

TWST recorded a free cash flow (TTM) of -$128.84 million for the quarter ending December 31, 2023, a +44.63% increase year-over-year.

Twist Bioscience Corp (TWST) Earnings per Share 2024

TWST earnings per share (TTM) was -$3.61 for the quarter ending December 31, 2023, a +6.48% growth year-over-year.

Twist Bioscience Corp Stock (TWST) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Leproust Emily M.	Chief Executive Officer	Apr 02 '24	Sale	32.74	1,132	37,057	514,149
Finn Patrick John	President and COO	Apr 02 '24	Sale	32.74	492	16,106	178,380
Banyai William	See Remark	Apr 02 '24	Sale	32.74	327	10,705	345,986
Green Paula	SVP of Human Resources	Apr 02 '24	Sale	32.74	229	7,497	92,421
Cho Dennis	See Remarks	Apr 02 '24	Sale	32.74	129	4,223	81,004
Leproust Emily M.	Chief Executive Officer	Mar 20 '24	Sale	33.52	1,128	37,806	515,281
Banyai William	See Remark	Mar 20 '24	Sale	33.52	442	14,814	346,313
Cho Dennis	See Remarks	Mar 20 '24	Sale	33.52	230	7,709	81,133
Green Paula	SVP of Human Resources	Mar 20 '24	Sale	33.52	200	6,703	92,650
Cho Dennis	See Remarks	Mar 14 '24	Sale	34.60	93	3,218	81,363

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company was founded in 2013 and is headquartered in San Francisco, California.